Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in Short Bowel Syndrome
NCT03371862Phase 2Withdrawn
- Sponsor
- Imperial College London
- Start
- Oct 2017
- Primary completion
- Aug 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of liraglutide in short bowel syndrome (SBS), sponsored by Imperial College London. Planned start Oct 2017; status: withdrawn.
02
Drugs
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on NCT03371862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03371862.